Insider Transactions in Q3 2025 at Nuo Therapeutics, Inc. (AURX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 01
2025
|
C Eric Winzer Director |
SELL
Payment of exercise price or tax liability
|
Direct |
27,659
-19.03%
|
$27,659
$1.74 P/Share
|
|
Aug 01
2025
|
C Eric Winzer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
120,313
+45.29%
|
$0
$0.4 P/Share
|
|
Aug 01
2025
|
Paul Mintz Director |
SELL
Payment of exercise price or tax liability
|
Direct |
20,115
-22.99%
|
$20,115
$1.74 P/Share
|
|
Aug 01
2025
|
Paul Mintz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
87,500
+50.0%
|
$0
$0.4 P/Share
|
|
Aug 01
2025
|
David Emerson Jorden CEO/CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,313
-0.98%
|
$21,313
$1.74 P/Share
|
|
Aug 01
2025
|
David Emerson Jorden CEO/CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
192,710
+4.35%
|
$0
$0.4 P/Share
|
|
Jul 31
2025
|
Peter Clausen CSO/COO |
BUY
Exercise of conversion of derivative security
|
Direct |
183,853
+19.27%
|
$0
$0.4 P/Share
|
|
Jul 30
2025
|
Scott M. Pittman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+0.07%
|
$3,946
$1.5 P/Share
|
|
Jul 30
2025
|
Charles E Sheedy > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
133,333
+1.14%
|
$133,333
$1.5 P/Share
|